Q&A: Isomorphic Labs CEO Demis Hassabis on $600M raise, AI biotech's future
Isomorphic Labs wants to achieve "maximum acceleration" on its drug discovery research progress, Demis Hassabis told Endpoints News. In an interview on Monday shortly after announcing the startup's first external financing round ...
Isomorphic Labs wants to achieve "maximum acceleration" on its drug discovery research progress, Demis Hassabis told Endpoints News.
In an interview on Monday shortly after announcing the startup's first external financing round ...
